Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
132.00    -3.50 (-2.58%)
Bid:
133.00
Ask:
139.50
Spread: 6.50 (4.887%)
Market Cap: £103.58m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Period end trading update

21 Jan 2010 07:00

RNS Number : 8908F
Xaar PLC
21 January 2010
 



FOR IMMEDIATE RELEASE

21 January 2010

Xaar plc

FULL YEAR TRADING UPDATE

Xaar plc ("Xaar"), the inkjet printing technology group headquartered in Cambridge, presents an update on trading performance for the year ended 31 December 2009.

Trading

Trading for the fourth quarter of 2009 and the year as a whole was in line with the Board's expectations and the financial results for the 12 months ended 31 December 2009 are expected to be in line with market expectations.

The trends reported in the IMS dated 14 October 2009 continued through to the year-end. OEM customers are continuing to develop digital printing machines incorporating Xaar's Platform 3 technology and, whilst some applications are now technically proven and contribute material revenue to Xaar, others still remain some way from full commercialisation. Xaar remains committed to providing its Platform 3 customers with the necessary support to bring these developments to a successful conclusion and has continued to incur some significant costs in doing this.

Sales of Platform 1 products continue to deliver the majority of Xaar's revenues through both new product launches and continuing sales of existing products, albeit at lower margins than seen historically. These lower margins are a direct result of the highly competitive nature of this market and, as is the case for Platform 3, higher than expected customer support costs for some of these products.

The project to transfer those manufacturing facilities located in Sweden to the Group's Huntingdon facility continues to be on track with completion scheduled for March 2011.

Whilst results for 2009 are expected to be in line with market consensus, the level of profitability reflected the benefits of the cost cutting programme previously implemented offset by the higher than anticipated product and customer support costs. The Board is continuing to take appropriate action to improve profitability and is planning on delivering improved results for 2010.

Cash

Net cash and cash equivalents at 31 December 2009 were approximately £11.1m (31 December 2008: £11.0m, 30 June 2009: £10.3m) after payment of £1.5dividends in the year.

Dividend

It is the Board's intention to recommend the payment of a final dividend, details of which will be provided at the time of the announcement of the final results for the year.

Announcement of final results

The detailed results for 2009 will be announced in accordance with Xaar's normal timetable on 17 March 2010.

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

 

 

 

Singer Capital Markets Limited:

020-3205-7626

Shaun Dobson

 

 

 

Bankside Consultants:

 

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSEFEFSFSSEEF
Date   Source Headline
3rd Feb 20254:15 pmRNSTotal Voting Rights
22nd Jan 202512:30 pmRNSBlock listing Interim Review
21st Jan 20253:00 pmRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading update & notification of full year results
15th Jan 20257:00 amRNSAppointment of Chief Financial Officer
11th Dec 202410:30 amRNS2024 Full Year Trading Update
4th Dec 202410:45 amRNSUpdate statement on 2024 AGM voting results
3rd Dec 202410:50 amRNSTotal Voting Rights
20th Nov 20247:00 amRNSBoard changes
1st Nov 202412:00 pmRNSTotal Voting Rights
1st Oct 202411:30 amRNSTotal Voting Rights
18th Sep 20247:00 amRNSInterim Results
2nd Sep 20241:45 pmRNSTotal Voting Rights
2nd Aug 20242:30 pmRNSHolding(s) in Company
1st Aug 202411:15 amRNSTotal Voting Rights
30th Jul 20247:00 amRNSNOTICE OF RESULTS AND UPDATE ON TRADING
3rd Jul 202411:45 amRNSBlock listing Interim Review
2nd Jul 20242:00 pmRNSTotal Voting Rights
28th Jun 202410:00 amRNSDirector Declaration
3rd Jun 20242:45 pmRNSTotal Voting Rights
30th May 202412:00 pmRNSBoard changes
29th May 20241:45 pmRNSResult of AGM
29th May 20249:30 amRNSHolding(s) in Company
21st May 20249:30 amRNSDirector/PDMR Shareholding
20th May 20244:30 pmRNSDirector/PDMR Shareholding
13th May 20249:42 amRNSHolding(s) in Company
1st May 20244:15 pmRNSTotal Voting Rights
30th Apr 20244:30 pmRNSDirector/PDMR Shareholding
22nd Apr 202410:51 amRNSAnnual Financial Report
2nd Apr 202412:00 pmRNSTotal Voting Rights
1st Mar 202410:15 amRNSTotal Voting Rights
26th Feb 20249:00 amRNSHolding(s) in Company
23rd Feb 202410:30 amRNSBoard Change
1st Feb 20241:32 pmRNSTotal Voting Rights
29th Jan 202412:04 pmRNSHolding(s) in Company
12th Jan 20243:15 pmRNSBlock listing Interim Review
12th Jan 20247:00 amRNSNotification of Results & Full year Guidance
8th Jan 202412:36 pmRNSTotal Voting Rights
12th Dec 20239:00 amRNSNotification of Transactions of Directors & PDMRs
11th Dec 20233:00 pmRNSNotification of Transactions of Directors & PDMRs
1st Dec 202311:00 amRNSTotal Voting Rights
1st Dec 202310:00 amRNSDirector Declaration
29th Nov 20237:00 amRNSTrading Update
17th Nov 20234:07 pmRNSHolding(s) in Company
9th Nov 20231:53 pmRNSDirector/PDMR Shareholding
3rd Nov 202310:52 amRNSHolding(s) in Company
1st Nov 20234:03 pmRNSTotal Voting Rights
30th Oct 20237:00 amRNSBoard Changes
2nd Oct 202311:45 amRNSTotal Voting Rights
21st Sep 20233:16 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.